BIOLOGICAL · Unmapped registry intervention
Zeushield Cytotoxic T Lymphocytes
Find medicine records ·
Find other trials using this name
Clinical trial
Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC)
NCT03060343
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedZeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC)
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: EARLY_PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Zeushield Cytotoxic T LymphocytesBIOLOGICAL
Sponsors & collaborators
Yu Fengleilead sponsor
Hunan Yongren Medical Innovation Co. Ltd.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03060343 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.